Aipeng Medical reports net loss of 9.88 million yuan in 2026 interim report

Jiemian··CN·Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Aipeng Medical released its 2026 interim report, showing total operating revenue of 149 million yuan, down 6.54% year on year, and a net loss attributable to the parent company of 9.88 million yuan. Net cash flow from operating activities was negative 12.05 million yuan, the asset-liability ratio was 15.88%, gross margin was 65.50%, return on equity was negative 1.50%, and diluted earnings per share was negative 0.08 yuan. The company had 24,000 shareholders, with the top ten shareholders holding 44.14% of shares.

Impact on assets 1

Others▼ · 1 stocks
© 2026 MarketIVNews